Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy
Anthony M. Hunter, Najla Al Ali, Anne Mai, Savan Shah, David M. Swoboda, Andrew Kuykendall, Chetasi Talati, Kendra Sweet, David A. Sallman, Jeffrey E. Lancet, Rami S. Komrokji, Eric Padron
Topics & Concepts
LeukocytosisChronic myelomonocytic leukemiaMedicineLeukemiaOncologyInternal medicineIntensive care medicineMyelodysplastic syndromesBone marrowAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsBone and Joint Diseases